These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Pancreatic glucagon: possible implications of the hyperglycemic hormone in diabetes control. Gossain VV; Rovner DR Postgrad Med; 1982 Jul; 72(1):87-8, 91-3, 96. PubMed ID: 7088751 [TBL] [Abstract][Full Text] [Related]
23. Role of glucagon in human diabetic ketoacidosis: studies using somatostatin. Gerich JE; Schneider VS; Lorenzi M; Tsalikian E; Karam JH; Bier DM; Forsham PH Clin Endocrinol (Oxf); 1976; 5 Suppl():299S-305S. PubMed ID: 829924 [TBL] [Abstract][Full Text] [Related]
24. Glucagon-induced increase in plasma potassium levels in type 1 (insulin-dependent) diabetic subjects. Cagliero E; Martina V; Massara F; Molinatti GM Diabetologia; 1983 Feb; 24(2):85-7. PubMed ID: 6132848 [TBL] [Abstract][Full Text] [Related]
25. Evidence for an intrahepatic contribution to the waning effect of glucagon on glucose production in the conscious dog. Cherrington AD; Diamond MP; Green DR; Williams PE Diabetes; 1982 Oct; 31(10):917-22. PubMed ID: 6759225 [TBL] [Abstract][Full Text] [Related]
26. Glucose homeostasis during prolonged suppression of glucagon and insulin secretion by somatostatin. Sherwin RS; Hendler R; DeFronzo R; Wahren J; Felic P Proc Natl Acad Sci U S A; 1977 Jan; 74(1):348-52. PubMed ID: 264686 [TBL] [Abstract][Full Text] [Related]
27. Glucose, insulin and glucagon in the diabetic goose. Karmann H; Mialhe P Horm Metab Res; 1976 Nov; 8(6):419-26. PubMed ID: 1002101 [TBL] [Abstract][Full Text] [Related]
28. The role of glucagon in diabetes. Unger RH; Orci L Compr Ther; 1982 Jan; 8(1):53-9. PubMed ID: 7039948 [TBL] [Abstract][Full Text] [Related]
29. The inhibitory effect of somatostatin on growth hormone, insulin and glucagon secretion in diabetes mellitus. Ward FR; Leblanc H; Yen SS J Clin Endocrinol Metab; 1975 Sep; 41(3):527-32. PubMed ID: 1159060 [TBL] [Abstract][Full Text] [Related]
30. Glucose counterregulation, hypoglycemia, and intensive insulin therapy in diabetes mellitus. Cryer PE; Gerich JE N Engl J Med; 1985 Jul; 313(4):232-41. PubMed ID: 2861565 [TBL] [Abstract][Full Text] [Related]
31. Glucagonocentric restructuring of diabetes: a pathophysiologic and therapeutic makeover. Unger RH; Cherrington AD J Clin Invest; 2012 Jan; 122(1):4-12. PubMed ID: 22214853 [TBL] [Abstract][Full Text] [Related]
32. Inhibition of glucagon secretion. Young A Adv Pharmacol; 2005; 52():151-71. PubMed ID: 16492545 [TBL] [Abstract][Full Text] [Related]
33. THE ROLE OF GLUCAGON IN THE PATHOPHYSIOLOGY AND MANAGEMENT OF DIABETES. Kulina GR; Rayfield EJ Endocr Pract; 2016 May; 22(5):612-21. PubMed ID: 26866706 [TBL] [Abstract][Full Text] [Related]
34. Glucagon and hyperglycaemia in diabetes. Cryer PE Clin Sci (Lond); 2008 May; 114(9):589-90. PubMed ID: 18197838 [TBL] [Abstract][Full Text] [Related]
35. [Role of insulin resistance in the pathogenesis of diabetes mellitus]. Reaven GM Medicina (B Aires); 1978; 38(5):577-86. PubMed ID: 368502 [No Abstract] [Full Text] [Related]
36. Transient stimulatory effect of sustained hyperglucagonemia on splanchnic glucose production in normal and diabetic man. Bomboy JD; Lewis SB; Lacy WW; Sinclair-Smith BC; Liljenquist JE Diabetes; 1977 Mar; 26(3):177-4. PubMed ID: 190074 [TBL] [Abstract][Full Text] [Related]
37. Lack of suppression of glucagon contributes to postprandial hyperglycemia in subjects with type 2 diabetes mellitus. Shah P; Vella A; Basu A; Basu R; Schwenk WF; Rizza RA J Clin Endocrinol Metab; 2000 Nov; 85(11):4053-9. PubMed ID: 11095432 [TBL] [Abstract][Full Text] [Related]
38. Diabetogenic effects of somatostatin in maturity-onset diabetes and normal man: primacy of insulin deficiency rather than glucagon excess in the pathogenesis of diabetes. Sherwin RS; Tamborlane WV; Hendler R; Felig P Metabolism; 1978 Sep; 27(9 Suppl 1):1433-6. PubMed ID: 683012 [No Abstract] [Full Text] [Related]